Dr. David J. Brailer

Independent Director

With his background as a physician, health-technology entrepreneur, senior healthcare executive and former U.S. National Coordinator for Health Information Technology, Dr. Brailer provides the Board with deep insight into healthcare systems, digital health and healthcare innovation, as well as significant public company board experience.

Dr. Brailer joined the Board of Directors in 2026.

Dr. Brailer has served as Chairman and Chief Executive Officer of medem.ai, a health-tech company, since 2024, as Founder and Executive Chairman of Health Evolution since 2010, and as Founder and Managing Partner of Health Evolution Partners since 2007. Since 2021, he has served as Vice Chairman of the Duke Margolis Health Policy Institute.

From 2022 to 2026, Dr. Brailer served as Chief Health Officer of The Cigna Group and, from 2024 to 2026, also as its Chief Transformation Officer. From 2004 to 2006, he served as the U.S. National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services. From 2002 to 2004, he served as Senior Advisor to the U.S. Domestic Policy Council and National Economic Council. From 1992 to 2002, he served as Chairman and Chief.

Executive Officer of CareScience, Inc.
Dr. Brailer previously served on the boards of directors of Prolacta Bioscience, Inc. from 2012 to 2023, Walgreens Boots Alliance, Inc. from 2012 to 2021, and Kisimul Holdings from 2012 to 2019.

Dr. Brailer received a Ph.D. in Management Science and Applied Economics from The Wharton School of the University of Pennsylvania, and an M.D., with honors, and a B.S., cum laude, from West Virginia University.

Dr. Brailer serves as a Member of our Human Resources and Compensation and Compliance Committees.